[1]姜雄平,李慧义,陈桂良,等.药品标准中有关物质HPLC测定的几点意见[J].中国药品标准,2013,14(3):163-167. [2] 中国药典2010年版第一增补本[S].北京:中国医药科技出版社,2012:466,443,502. [3] 魏长峰,李平原,宋玉平等.UPLC法测定氨苄西林有关物质[J].药学研究,2014,33(3):148-149,152. [4] 杨倩, 袁雯玮.超高效液相色谱法测定盐酸博来霉素的有关物质[J].药物分析杂志.2015,35(4):679-684. [5] 中国药典2010年版(二部)[S].北京:中国医药科技出版社,2010:73,1031. [6] 池舒耀,孙晋红,彭蕾,等.超高效液相色谱法测定双氯芬酸钠的有关物质[J].广东化工,2014,41(4):87-88. [7] 海丽萍,杨东菁.UPLC法同时测定盐酸阿糖胞苷原料药的含量和有关物质[J].中国药房,2014,25(12):1137-1140. [8] Makielski JC, Valdivia CR. Ranolazine and late cardiac sodium current-a therapeutic target for angina, arrhythmia and more [J]. Br J Pharmacol, 2006, 148: 4?6. [9] 唐静雅, 王 薇, 李 黎,等. LC-MSn法研究雷诺嗪在比格犬尿中的主要代谢物[J].药学学报, 2012, 47(8): 1031-1038. [10] Vakamulla Malati, Anumala Raghupati Reddy, K. Mukkanti, et al. A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product[J]. Talanta.2012,97:563-573. [11] Ch. Krishnaiah, M. Vishnu Murthy, Ramesh Kumar, et al. Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage form[J]. Journal of Pharmaceutical and Biomedical Analysis.2011.54:667-673. [12] A. Nageswari,K.V.S.R. Krishna Reddy,K. Mukkanti. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms[J]. Journal of Pharmaceutical and Biomedical Analysis. 2012,66:109-115. [13] 颜晓丹,高明,蔡振华,等.HPLC、UPLC测定利培酮片中有关物质的比较研究[J].安徽医药,2012,16(11):1604-1606. [14] 刘杨,易大为,刘亚威,等.超高效液相色谱法测定氯霉素滴眼液的含量及有关物质[J].中国药品标准,2012,13(6):433-436. [15] 矫筱蔓,赵晓冬,王全一.UPLC测定注射用头孢哌酮钠舒巴坦钠[J].药物分析杂志.2011,31(3):504-508. [16] 张婷婷, 马辰. 奥利司他中有关物质的UPLC-MS/MS研究[J]. 药学学报, 2014, 49(3): 380-384. [17] 陈佳,王钢力,姚令文,等.超高效液相色谱(UPLC)在药物分析领域中的应用[J].药物分析杂志.2008,28(11):1976-1981.
|